Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$905.38 3.66 (0.4%) as of 4:30 Fri 6/28


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 866.07(B)
Last Volume: 3,374,911 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,771,329 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 50 93
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1436
  Page 42 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lechleiter John C Director   –       •      –    2017-02-01 4 D $77.03 $1,671,243 D/D (21,696) 834,291     -
   Lechleiter John C Director   –       •      –    2017-02-01 4 OE $0.00 $0 D/D 46,097 855,987     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2017-02-01 4 D $77.03 $349,947 D/D (4,543) 84,889     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2017-02-01 4 OE $0.00 $0 D/D 9,732 89,432     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2017-02-01 4 D $77.03 $277,924 D/D (3,608) 78,944     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2017-02-01 4 OE $0.00 $0 D/D 7,683 82,552     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2017-02-01 4 D $77.03 $287,476 D/D (3,732) 113,581     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2017-02-01 4 OE $0.00 $0 D/D 8,195 117,313     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2017-02-01 4 D $77.03 $370,514 D/D (4,810) 139,217     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2017-02-01 4 OE $0.00 $0 D/D 10,244 144,027     -
   Lilly Endowment Inc 10% Owner   –       –       •   2017-02-01 4 S $77.34 $17,016,840 D/D (220,000) 125,355,804     -
   Luciano Juan R Director   –       •      –    2017-01-31 4 A $76.85 $9,683 D/D 126 2,040     -
   Alvarez Ralph Director   –       •      –    2017-01-31 4 A $76.85 $10,913 D/D 142 35,203     -
   Zulueta Alfonso G SVP& Pres., Emerging Markets   •       –      –    2017-01-27 4 A $75.38 $991,247 D/D 13,150 57,051     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2017-01-27 4 A $75.38 $194,933 D/D 2,586 2,886     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2017-01-27 4 A $75.38 $643,670 I/I 8,539 40,190     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2017-01-27 4 A $75.38 $684,526 D/D 9,081 64,699     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2017-01-27 4 A $75.38 $1,549,134 D/D 20,551 131,509     -
   Ricks David A President & CEO   •       •      –    2017-01-27 4 A $75.38 $1,521,395 D/D 20,183 99,156     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2017-01-27 4 A $75.38 $2,938,312 D/D 38,980 38,980     -
   Peterson Barton R Sr. VP, Corp. Affairs & Comm.   •       –      –    2017-01-27 4 A $75.38 $837,924 D/D 11,116 105,324     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2017-01-27 4 A $75.38 $153,021 I/I 2,030 13,509     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2017-01-27 4 A $75.38 $1,450,537 D/D 19,243 86,308     -
   Lundberg Jan M EVP,Science&Tech and Pres. LRL   •       –      –    2017-01-27 4 A $75.38 $2,432,362 D/D 32,268 147,002     -
   Lechleiter John C Director   –       •      –    2017-01-27 4 A $75.38 $7,011,923 D/D 93,021 809,890     -
  1436 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 42 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us